Salt - A potential 'uremic toxin'?

Blood Purification

Volumn 24, Issue 1, 2006, Pages 63-66

  Ritz, Eberhard ^a   Dikow, Ralf ^a   Morath, Christian ^a   Schwenger, Vedat ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Aldosterone; Aortic stiffness; Left ventricular hypertrophy; Oxidative stress

Indexed keywords

ALDOSTERONE; SODIUM CHLORIDE; UREMIC TOXIN;

AORTA DISEASE; BLOOD PRESSURE MEASUREMENT; DIALYSIS; HEART LEFT VENTRICLE HYPERTROPHY; HYPERTENSION; KIDNEY FAILURE; MICROALBUMINURIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SODIUM LOAD; TISSUE INJURY;

ALBUMINURIA; BLOOD PRESSURE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; OXIDATIVE STRESS; RENAL DIALYSIS; SODIUM CHLORIDE; WATER-ELECTROLYTE BALANCE;

EID: 29244450506     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089439     Document Type: Review

References (44)

1. Bergier JF: Une Histoire du Sel. Fribourg, Office du Livre SA, 1982.
2. Ritz E: The history of salt - Aspects of interest to the nephrologist. Nephrol Dial Transplant 1996;11:969-975.
3. Denton D: The Hunger for Salt. Berlin, Springer, 1984.
4. Weisinger RS, Blair-West JR, Burns P, Denton DA, McKinley MJ, Tarjan E: The role of angiotensin II in ingestive behaviour: a brief review of angiotensin II, thirst and Na appetite. Regul Pept 1996;66:73-81.
5. Abrams HL Jr: Salt and sodium: an anthropological cross cultural perspective in health and disease. J Appl Nutr 1983;35:127-158.
6. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, et al: The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995;1:1009-1016.
7. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH: Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.
8. He FJ, MacGregor GA: How far should salt intake be reduced? Hypertension 2003;42:1093-1099.
9. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK: Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999;282:2027-2034.
10. Geleijnse JM, Hofman A, Witteman JC, Hazebroek AA, Valkenburg HA, Grobbee DE: Long-term effects of neonatal sodium restriction on blood pressure. Hypertension 1997;29:913-917.
11. Guyton AC: Dominant role of the kidneys and accessory role of whole-body autoregulation in the pathogenesis of hypertension. Am J Hypertens 1989;2:575-585.
12. Guyton AC, Coleman TG: Quantitative analysis of the pathophysiology of hypertension. 1969. J Am Soc Nephrol 1999;10:2248-2258.
13. Charra B, Bergstrom J, Scribner BH: Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 1998;32:720-724.
14. + storage in the skin. Am J Physiol Heart Circ Physiol 2004;287:H203-H208.
15. Messerli FH, Schmieder RE, Weir MR: Salt. A perpetrator of hypertensive target organ disease? Arch Intern Med 1997;157:2449-2452.
16. du Cailar G, Mimran A: Sodium and left ventricular hypertrophy in patients with hypertension. Arch Mal Coeur Vaiss 1995;88:15-19.
17. du Cailar G, Mimran A, Fesler P, Ribstein J, Blacher J, Safar ME: Dietary sodium and pulse pressure in normotensive and essential hypertensive subjects. J Hypertens 2004;22:697-703.
18. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A: Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848-851.
19. Sanders PW: Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension 2004;43:142-146.
20. Suzuki H, Yamamoto T, Ikegaya N, Hishida A: Dietary salt intake modulates progression of antithymocyte serum nephritis through alteration of glomerular angiotensin II receptor expression. Am J Physiol Renal Physiol 2004;286:F267-F277.
21. Benstein JA, Feiner HD, Parker M, Dworkin LD: Superiority of salt restriction over diuretics in reducing renal hypertrophy and injury in uninephrectomized SHR. Am J Physiol 1990;258:F1675-F1681.
22. Sanders PW, Gibbs CL, Akhi KM, MacMillan-Crow LA, Zinn KR, Chen YF, Young CJ, Thompson JA: Increased dietary salt accelerates chronic allograft nephropathy in rats. Kidney Int 2001;59:1149-1157.
23. Sanders MW, Fazzi GE, Janssen GM, Blanco CE, De Mey JG: High sodium intake increases blood pressure and alters renal function in intrauterine growth-retarded rats. Hypertension 2005;46:71-75.
24. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998;98:2621-2628.
25. Verhave JC, Hillege HL, Burgerhof JG, Janssen WM, Gansevoort RT, Navis GJ, de Zeeuw D, de Jong PE: Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004;256:324-330.
26. Cianciaruso B, Bellizzi V, Minutolo R, Tavera A, Capuano A, Conte G, De Nicola L: Salt intake and renal outcome in patients with progressive renal disease. Miner Electrolyte Metab 1998;24:296-301.
27. Rocha R, Funder JW: The pathophysiology of aldosterone in the cardiovascular system. Ann NY Acad Sci 2002;970:89-100.
28. Joffe HV, Adler GK: Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 2005;10:31-37.
29. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Intern Organs 1960;6:114-122.
30. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. 1960. J Am Soc Nephrol 1998;9:719-726.
31. Dorhout Mees EJ: Volaemia and blood pressure in renal failure: have old truths been forgotten. Nephrol Dial Transplant 1995;10:1297-1298.
32. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-1291.
33. Ozkahya M, Ok E, Cirit M, Aydin S, Akcicek F, Basci A, Dorhout Mees EJ: Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs. Nephrol Dial Transplant 1998;13:1489-1493.
34. Ozkahya M, Toz H, Qzerkan F, Duman S, Ok E, Basci A, Mees EJ: Impact of volume control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002;15:655-660.
35. Krautzig S, Janssen U, Koch KM, Granolleras C, Shaldon S: Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998;13:552-553.
36. du Cailar G, Gallay P, Ribstein J, Daures JP, Grolleau R, Mimran A: Myocardial morphological changes related to sodium intake in normotensive and hypertensive patients never treated before. Arch Mal Coeur Vaiss 1990;83:2045-2049.
37. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H: Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 2002;17:1713-1724.
38. Tycho Vuurmans JL, Boer WH, Bos WJ, Blankestijn PJ, Koomans HA: Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients. J Am Soc Nephrol 2002;13:177-183.
39. Oberg BP, McMenamin E, Lucas FL, Mc-Monagle E, Morrow J, Ikizler TA, Himmelfarb J: Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004;65:1009-1016.
40. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, Wilcox CS: Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 2003;14:2775-2782.
41. Takahashi S, Seki M, Ishida J, Satou M, Sakurai T, Narusaka M, Kamiya A, Nakajima M, Enju A, Akiyama K, Yamaguchi-Shinozaki K, Shinozaki K: Monitoring the expression profiles of genes induced by hyperosmotic, high salinity, and oxidative stress and abscisic acid treatment in Arabidopsis cell culture using a full-length cDNA microarray. Plant Mol Biol 2004;56:29-55.
42. Chaparzadeh N, D'Amico ML, Khavari-Nejad RA, Izzo R, Navari-Izzo F: Antioxidative responses of Calendula officinalis under salinity conditions. Plant Physiol Biochem 2004;42:695-701.
43. Kushiro T, Fujita H, Hisaki R, Asai T, Ichiyama I, Kitahara Y, Koike M, Sugiura H, Saito F, Otsuka Y, Kanmatsuse K: Oxidative stress in the Dahl salt-sensitive hypertensive rat. Clin Exp Hypertens 2005;27:9-15.
44. Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr: Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005;45:934-939.